Alzheimer Drug Lecanemab Granted Full FDA Approval
FDA's action, based on confirmatory evidence showing slowed disease progression, follows a January 2023 accelerated approval.
LAMA-LABA Treatment for COPD More Effective than ICS-LBA: New Findings
Results of a new study offer additional support for clinical guidelines to favor one therapy over another, authors suggest.
